With global scale, deep scientific expertise and a disciplined growth strategy, Teva is helping shape the next chapter of biopharmaceutical innovation. We are seeking partners who can help advance science to better health.
What We're Looking For
We are focused on partnership opportunities in:
Innovative Medicines
Late-stage assets / clinically validated mechanisms where Teva’s scientific expertise, R&D capabilities and commercial scale can maximize development, launch and long-term value creation
Biosimilars
Opportunities to expand our global biosimilars portfolio, leveraging deep expertise in biologics and complex generics
Generics
Exclusive launch opportunities and value-added assets where Teva’s global reach, market access capabilities and scale can maximize value
We are focused on two priority therapeutic areas for Innovative Medicines:
Neuroscience
- Movement disorders: dyskinesia, Tourette syndrome, Parkinson’s disease, ataxia and related conditions
- Psychiatry: schizophrenia, psychosis in dementia, mood disorders (bipolar disorder, depression and related conditions)
- Rare: neurological, neuromuscular, and neurodevelopmental disorders
Immunology
- Gastroenterology: Crohn’s disease, ulcerative colitis and related conditions
- Dermatology: atopic dermatitis, vitiligo and related conditions
- Respiratory: asthma
- Rare: inflammatory and immunological diseases
Note: This is a representative list of disease areas - not exhaustive.
In Biosimilars, we are focused on opportunities in the following areas:
Biosimilars Areas of Interest
- Partnerships that can expand our biosimilar portfolio across therapeutic areas (e.g. oncology, immunology, ophthalmology, respiratory, metabolic diseases etc.)
- Seeking opportunities for global expansion and for regional commercialization
How We Work
We take a strategic, integrated approach to business development:
Integrated Mindset
We bring R&D and commercial together to assess opportunities.
Focused & Disciplined
We prioritize partnerships aligned with our strategy and long-term value creation.
Committed to Execution
We stay closely engaged beyond the deal to drive successful outcomes.
Why Partner with Teva
Great partnerships start with shared purpose. Teva brings the scale, expertise and commitment to help unlock long-term value together.
Global Scale & Reach
A strong global footprint across key markets
Balanced Portfolio
Expertise across innovative medicines, generics and biosimilars
Proven Partnering
Proven experience building strategic partnerships across deal structures
Learn more about Teva's therapeutic areas and scientific focus
Interested in partnering
with Teva?
Connect with our Business Development team
Latest in Business Development
Teva Closes Acquisition of Emalex Biosciences, Strengthening Late-Stage Neuroscience Pipeline and Advancing Pivot to Growth Strategy
Teva and Blackstone Life Sciences Announce $400 Million Strategic Growth Capital Agreement to Advance duvakitug
Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo
Teva Innovative Portfolio and Consistent Execution of Pivot to Growth Strategy Deliver Third Consecutive Year of Growth; Pipeline Positioned to Unlock Significant Value Potential
“I Think People are Starting to Get That There’s a Lot of Upside at Teva”
Evan Lippman, Executive Vice President of Business Development